Lambrolizumab Typical Properties
Name
CAS
Purity
Package
CB-03-01
19608-29-8
98%
10G/BAG
Setipiprant
866460-33-5
98%
100G/BAG
RU58841
154992-24-2
98%
100G/BAG
Lambrolizumab Usage
Pembrolizumab is a humanized antibody used in cancer immunotherapy. It is an IgG4 isotype antibody that blocks a protective mechanism of cancer cells, and allows the immune system to destroy those cancer cells. It targets the programmed cell death 1 (PD-1) receptor of lymphocytes. The FDA initially approved it to treat metastatic melanoma.
Application Pharma grade or research purpose
Shelf life 2 years
Lambrolizumab Supply Ability
1000 Kilogram/Kilograms per Month
Lambrolizumab Storage
1G 10G 100G/BAG
